Literature DB >> 22362629

Causal inference in epidemiological studies with strong confounding.

Kelly L Moore1, Romain Neugebauer, Mark J van der Laan, Ira B Tager.   

Abstract

One of the identifiability assumptions of causal effects defined by marginal structural model (MSM) parameters is the experimental treatment assignment (ETA) assumption. Practical violations of this assumption frequently occur in data analysis when certain exposures are rarely observed within some strata of the population. The inverse probability of treatment weighted (IPTW) estimator is particularly sensitive to violations of this assumption; however, we demonstrate that this is a problem for all estimators of causal effects. This is due to the fact that the ETA assumption is about information (or lack thereof) in the data. A new class of causal models, causal models for realistic individualized exposure rules (CMRIER), is based on dynamic interventions. CMRIER generalize MSM, and their parameters remain fully identifiable from the observed data, even when the ETA assumption is violated, if the dynamic interventions are set to be realistic. Examples of such realistic interventions are provided. We argue that causal effects defined by CMRIER may be more appropriate in many situations, particularly those with policy considerations. Through simulation studies, we examine the performance of the IPTW estimator of the CMRIER parameters in contrast to that of the MSM parameters. We also apply the methodology to a real data analysis in air pollution epidemiology to illustrate the interpretation of the causal effects defined by CMRIER.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362629      PMCID: PMC4113478          DOI: 10.1002/sim.4469

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Bayesian inference for a generalized population attributable fraction: the impact of early vitamin A levels on chronic lung disease in very low birthweight infants.

Authors:  P Graham
Journal:  Stat Med       Date:  2000-04-15       Impact factor: 2.373

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

4.  Causal effect models for realistic individualized treatment and intention to treat rules.

Authors:  Mark J van der Laan; Maya L Petersen
Journal:  Int J Biostat       Date:  2007       Impact factor: 0.968

5.  Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules.

Authors:  Oliver Bembom; Mark J van der Laan
Journal:  Stat Med       Date:  2008-08-30       Impact factor: 2.373

6.  Causal inference in longitudinal studies with history-restricted marginal structural models.

Authors:  Romain Neugebauer; Mark J van der Laan; Marshall M Joffe; Ira B Tager
Journal:  Electron J Stat       Date:  2007-01-01       Impact factor: 1.125

7.  A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods.

Authors:  J Robins
Journal:  J Chronic Dis       Date:  1987

8.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

9.  When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Authors:  Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

10.  Ambient ozone concentrations cause increased hospitalizations for asthma in children: an 18-year study in Southern California.

Authors:  Kelly Moore; Romain Neugebauer; Fred Lurmann; Jane Hall; Vic Brajer; Sianna Alcorn; Ira Tager
Journal:  Environ Health Perspect       Date:  2008-08       Impact factor: 9.031

  10 in total
  18 in total

1.  A causal model for joint evaluation of placebo and treatment-specific effects in clinical trials.

Authors:  Zhiwei Zhang; Richard M Kotz; Chenguang Wang; Shiling Ruan; Martin Ho
Journal:  Biometrics       Date:  2013-02-22       Impact factor: 2.571

2.  Causal Modeling in Environmental Health.

Authors:  Marie-Abèle Bind
Journal:  Annu Rev Public Health       Date:  2019-01-11       Impact factor: 21.981

3.  Best Practices for Gauging Evidence of Causality in Air Pollution Epidemiology.

Authors:  Francesca Dominici; Corwin Zigler
Journal:  Am J Epidemiol       Date:  2017-12-15       Impact factor: 4.897

Review 4.  Causal models and learning from data: integrating causal modeling and statistical estimation.

Authors:  Maya L Petersen; Mark J van der Laan
Journal:  Epidemiology       Date:  2014-05       Impact factor: 4.822

5.  Estimating the effect of cumulative occupational asbestos exposure on time to lung cancer mortality: using structural nested failure-time models to account for healthy-worker survivor bias.

Authors:  Ashley I Naimi; Stephen R Cole; Michael G Hudgens; David B Richardson
Journal:  Epidemiology       Date:  2014-03       Impact factor: 4.822

6.  Joint Estimation of Treatment and Placebo Effects in Clinical Trials with Longitudinal Blinding Assessments.

Authors:  Wei Liu; Zhiwei Zhang; R Jason Schroeder; Martin Ho; Bo Zhang; Cynthia Long; Hui Zhang; Telba Z Irony
Journal:  J Am Stat Assoc       Date:  2016-08-18       Impact factor: 5.033

7.  G-computation of average treatment effects on the treated and the untreated.

Authors:  Aolin Wang; Roch A Nianogo; Onyebuchi A Arah
Journal:  BMC Med Res Methodol       Date:  2017-01-09       Impact factor: 4.615

8.  The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.

Authors:  Yara Backes; Sjoerd G Elias; Bibie S Bhoelan; John N Groen; Jeroen van Bergeijk; Tom C J Seerden; Hendrikus J M Pullens; Bernhard W M Spanier; Joost M J Geesing; Koen Kessels; Marjon Kerkhof; Peter D Siersema; Wouter H de Vos Tot Nederveen Cappel; Niels van Lelyveld; Frank H J Wolfhagen; Frank Ter Borg; G Johan A Offerhaus; Miangela M Lacle; Leon M G Moons
Journal:  BMC Med       Date:  2017-07-14       Impact factor: 8.775

9.  Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.

Authors:  Claire Dupuis; Etienne de Montmollin; Niccolò Buetti; Dany Goldgran-Toledano; Jean Reignier; Carole Schwebel; Julien Domitile; Mathilde Neuville; Moreno Ursino; Shidasp Siami; Stéphane Ruckly; Corinne Alberti; Bruno Mourvillier; Sebastien Bailly; Virginie Laurent; Marc Gainnier; Bertrand Souweine; Jean-François Timsit
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

10.  Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes.

Authors:  Romain Neugebauer; Bruce Fireman; Jason A Roy; Patrick J O'Connor
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.